850524 | CHEMS
cholesteryl hemisuccinate

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
CHEMS
cholesteryl hemisuccinate
CAS Registry Number is a Registered Trademark of the American Chemical Society
5-Cholesten-3β-ol
3-hemisuccinate
CHS
Cruz N, Pinho JO, Soveral G, Ascensão L, Matela N, Reis C, Gaspar MM. A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy. Nanomaterials (Basel). 2020 Apr 6;10(4):693. doi: 10.3390/nano10040693. PMID: 32268611; PMCID: PMC7221742.
PubMed ID: 32268611Wang YQ, Ji MY, Wang C. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy. Int J Pharm. 2020 May 30;582:119331. doi: 10.1016/j.ijpharm.2020.119331. Epub 2020 Apr 11. PMID: 32289484.
PubMed ID: 32289484Yao Y , Feng L , Wang Z , Chen H , Tan N . Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoring. Biomater Sci. 2019 Dec 17;8(1):256-265. doi: 10.1039/c9bm00905a. PMID: 31687671.
PubMed ID: 31687671Samaddar S, Mazur J, Boehm D, Thompson DH. Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules. Int J Nanomedicine. 2019 Dec 4;14:9547-9561. doi: 10.2147/IJN.S225172. PMID: 31824150; PMCID: PMC6900316.
PubMed ID: 31824150Li Y, Zhai Y, Liu W, Zhang K, Liu J, Shi J, Zhang Z. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor. J Nanobiotechnology. 2019 Nov 29;17(1):117. doi: 10.1186/s12951-019-0550-7. PMID: 31783863; PMCID: PMC6884872.
PubMed ID: 31783863Ramesh A, Brouillard A, Kumar S, Nandi D, Kulkarni A. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 2020 Jan;227:119559. doi: 10.1016/j.biomaterials.2019.119559. Epub 2019 Oct 19.
PubMed ID: 31670078Ramesh A, Brouillard A, Kumar S, Nandi D, Kulkarni A. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 2020 Jan;227:119559. doi: 10.1016/j.biomaterials.2019.119559. Epub 2019 Oct 19.
PubMed ID: 31670078Roth MS, Westcott DJ, Iwai M, Niyogi KK. Hexokinase is necessary for glucose-mediated photosynthesis repression and lipid accumulation in a green alga. Commun Biol. 2019 Sep 19;2:347. doi: 10.1038/s42003-019-0577-1. eCollection 2019.
PubMed ID: 31552300Mozumder S, Bej A, Srinivasan K, Mukherjee S, Sengupta J. Comprehensive structural modeling and preparation of human 5-HT2A G-protein coupled receptor in functionally active form. Biopolymers. 2019 Aug 30:e23329. doi: 10.1002/bip.23329. [Epub ahead of print]
PubMed ID: 31469412Kanamala M, Palmer BD, Jamieson SM, Wilson WR, Wu Z. Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. Nanomedicine (Lond). 2019 Aug;14(15):1971-1989. doi: 10.2217/nnm-2018-0510. Epub 2019 Jul 29.
PubMed ID: 31355712Dolstra CC, Rinker T, Sankhagowit S, Deng S, Ting C, Dang AT, Kuhl TL, Sasaki DY. Mechanism of Acid-Triggered Cargo Release from Lipid Bilayer-Coated Mesoporous Silica Particles. Langmuir. 2019 Aug 13;35(32):10276-10285. doi: 10.1021/acs.langmuir.9b01087. Epub 2019 Jul 22.
PubMed ID: 31280569Huang X, Chau Y. Investigating impacts of surface charge on intraocular distribution of intravitreal lipid nanoparticles. Exp Eye Res. 2019 Jun 22;186:107711. doi: 10.1016/j.exer.2019.107711. [Epub ahead of print]
PubMed ID: 31238078Kim H, Nobeyama T, Honda S, Yasuda K, Morone N, Murakami T. Membrane fusogenic high-density lipoprotein nanoparticles. Biochim Biophys Acta Biomembr. 2019 Jun 14. pii: S0005-2736(19)30139-7. doi: 10.1016/j.bbamem.2019.06.007. [Epub ahead of print]
PubMed ID: 31207206Ramesh, A., Natarajan, S.K., Nandi, D. et al. Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor. Cel. Mol. Bioeng. (2019). doi: 10.1007/s12195-01900576-1
Pinho JO, Amaral JD, Castro RE, Rodrigues CM, Casini A, Soveral G, Gaspar MM. Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models. Nanomedicine (Lond). 2019 Apr;14(7):835-850. doi: 10.2217/nnm-2018-0388. Epub 2019 Mar 15.
PubMed ID: 30875274Thompson AA, Liu JJ, Chun E, Wacker D, Wu H, Cherezov V, Stevens RC. GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles. Methods. 2011 Dec;55(4):310-7. doi: 10.1016/j.ymeth.2011.10.011. Epub 2011 Oct 21.
PubMed ID: 22041719Bicelles can be integrated into standard crystallization protocols, and in contrast to micelles, bicelles maintain the protein in a more native bilayer environment allowing proteins to be captured in a more biologically relevant orientation. Reference/Protocol
- Certificate of Analysis (Lot No. 850524P-1G-A-014 and 5703PQA014)
- Certificate of Analysis (Lot No. 850524P-5G-A-014 and 5703PRA014)
- Certificate of Analysis (Lot No. 850524P-1G-B-014 and 5703PQB014)
- Certificate of Analysis (Lot No. 850524P-5G-B-014 and 5703PRB014)
- Certificate of Analysis (Lot No. 850524P-1G-C-014 and 5703PQC014)
- Certificate of Analysis (Lot No. 850524P-1G-D-014 and 5703PQD014)
- Certificate of Analysis (Lot No. 850524P-5G-C-014 and 5703PRC014)
- Certificate of Analysis (Lot No. 850524P-1G-E-014 and 5703PQE014)
- Certificate of Analysis (Lot No. 850524P-1G-F-014 and 5703PQF014)
- Certificate of Analysis (Lot No. 850524P-5G-D-014 and 5703PRD014)
- Certificate of Analysis (Lot No. 850524P-5G-E-014 and 5703PRE014)
- Certificate of Analysis (Lot No. 850524P-5G-A-015 and 5703PRA015)
- Certificate of Analysis (Lot No. 850524P-1G-G-014 and 5703PQG014)
- Certificate of Analysis (Lot No. 850524P-5G-B-015 and 5703PRB015)
- Certificate of Analysis (Lot No. 850524P-1G-A-015 and 5703PQA015)
- Certificate of Analysis (Lot No. 850524P-1G-B-015 and 5703PQB015)
- Certificate of Analysis (Lot No. 850524P-5G-E-015 and 5703PRE015)
- Certificate of Analysis (Lot No. 850524P-1G-C-015 and 5703PQC015)
- Certificate of Analysis (Lot No. 850524P-1G-D-015 and 5703PQD015)
- Certificate of Analysis (Lot No. 850524P-5G-G-015 and 5703PRG015)
- Certificate of Analysis (Lot No. 850524P-1G-E-015 and 5703PQE015)
- Certificate of Analysis (Lot No. 850524P-5G-F-015 and 5703PRF015)
- Certificate of Analysis (Lot No. 850524P-1G-F-015 and 5703PQF015)
- Certificate of Analysis (Lot No. 850524P-5G-H-015 and 5703PRH015)
- Certificate of Analysis (Lot No. 850524P-1G-G-015 and 5703PQG015)
- Certificate of Analysis (Lot No. 850524P-5G-I-015 and 5703PRI015)